Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration
about
Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible relationship between AMD and atherosclerosisThe significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical applicationSingle-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials.Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in IsraelSequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel.Influence of CFH, HTRA1 and ARMS2 polymorphisms in the response to intravitreal ranibizumab treatment for wet age-related macular degeneration in a Spanish population.Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration.Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.Genetic factors associated with age-related macular degeneration.Genetic predictors of response to photodynamictherapy.Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy.Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration.Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration.
P2860
Q26862738-AE156049-71F5-493F-883E-57FEBCEE157BQ34588115-74B98B73-4B59-4633-AAB8-9C57FFAB2EDEQ35995626-C9A4E0F5-FD6C-48D1-84DC-EFC51D82D058Q36934765-768D01B1-1651-440E-A385-985FA7D0E70FQ37000931-57C23305-DF7B-412C-9B77-BDA7FDC877A0Q37266897-F29B7303-DD0A-4B72-B5A0-847832BADE38Q37455410-7213CF5A-AB11-42AE-BD66-2B680BC405E0Q37792817-2D0546CB-E59A-4498-9F79-97C5AD634287Q37901276-9FE183F2-D691-42E0-A197-F623A2F29B24Q37931236-07E5EA3E-F7D1-4FAC-A9C2-1F5648E019A0Q41151732-90FE4127-199C-45CD-A04E-9B9B2BB56D6AQ42136459-BD245372-25CB-40BC-9016-4583F824BCCEQ54392848-DE713496-BD2B-4EEC-AE55-A7714ADA21F9
P2860
Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Clinical phenotypes associated ...... e-related macular degeneration
@ast
Clinical phenotypes associated ...... e-related macular degeneration
@en
type
label
Clinical phenotypes associated ...... e-related macular degeneration
@ast
Clinical phenotypes associated ...... e-related macular degeneration
@en
prefLabel
Clinical phenotypes associated ...... e-related macular degeneration
@ast
Clinical phenotypes associated ...... e-related macular degeneration
@en
P2093
P2860
P1476
Clinical phenotypes associated ...... e-related macular degeneration
@en
P2093
Alan Shiels
Jennifer M King
Milam A Brantley
Rajendra S Apte
Sean L Edelstein
Steven M Kymes
P2860
P304
P356
10.1016/J.AJO.2007.05.018
P407
P577
2007-07-12T00:00:00Z